ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Immunogenic cell death-related gene landscape predicts the overall survival and immune infiltration status of ovarian cancer

Zhang, Wenwen; Liu, Tianbo; Jiang, Liangliang; Chen, Jiarong; Li, Qiuli; Wang, Jing*哈尔滨医科大学
Frontiers in Genetics2022-11-8DOI: 10.3389/fgene.2022.1001239
6被引6阅读
引用收藏
分享

摘要

Background: Ovarian cancer (OC) is the most troubling malignant tumor of the female reproductive system. It has a low early diagnosis rate and a high tumor recurrence rate after treatment. Immunogenic cell death (ICD) is a unique form of regulated cell death that can activate the adaptive immune system through the release of DAMPs and cytokines in immunocompromised hosts and establish long-term immunologic memory. Therefore, this study aims to explore the prognostic value and underlying mechanisms of ICD-related genes in OC on the basis of characteristics.Methods: The gene expression profiles and related clinical information of OC were downloaded from The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) database. ICD-related genes were collected from the Genecards database. ICD-related prognostic genes were obtained by intersecting ICD-related genes with the OC prognostic-related genes that were analyzed in the TCGA database. Functional enrichment, genetic mutation, and immune infiltration correlation analyses were further performed to identify underlying mechanisms. Subsequently, we developed a TCGA cohort-based prognostic risk model that included a nine-gene signature through univariate and multivariate Cox regression and LASSO regression analyses. Meanwhile, external validation was performed on two sets of GEO cohorts and the TCGA training cohort for three other common tumors in women. In addition, a nomogram was established by integrating clinicopathological features and ICD-related gene signature to predict survival probability. Finally, functional enrichment and immune infiltration analyses were performed on the two risk subgroups.Results: By utilizing nine genes (ERBB2, RB1, CCR7, CD38, IFNB1, ANXA2, CXCL9, SLC9A1, and SLAMF7), we constructed an ICD-related prognostic signature. Subsequently, patients were subdivided into high- and low-risk subgroups in accordance with the median value of the risk score. In multivariate Cox regression analyses, risk score was an independent prognostic factor (hazard ratio = 2.783; p < 0.01). In the TCGA training cohort and the two GEO validation cohorts, patients with high-risk scores had worse prognosis than those with low-risk scores (p < 0.05). The time-dependent receiver operating characteristic curve further validated the prognostic power of the gene signature. Finally, gene set enrichment analysis indicated that multiple oncological pathways were significantly enriched in the high-risk subgroup. By contrast, the low-risk subgroup was strongly related to the immune-related signaling pathways. Immune infiltration analysis further illustrated that most immune cells showed higher levels of infiltration in the low-risk subgroup than in the high-risk subgroup.Conclusion: We constructed a novel ICD-related gene model for forecasting the prognosis and immune infiltration status of patients with OC. In the future, new ICD-related genes may provide novel potential targets for the therapeutic intervention of OC.

学科与关键词

关键词
ovarian cancerimmunogenic cell death (ICD)risk modelprognosisimmune infiltration
相关
加载中…
  • Immune Cell Infiltration Landscape of Ovarian Cancer to Identify Prognosis and Immunotherapy-Related Genes to Aid Immunotherapy
    Li, Xiushen; Liang, Weizheng; Zhao, Huanyi; Jin, Zheng; Shi, Guoqi; Xie, Wanhua; Wang, Hao*; Wu, Xueqing*Frontiers in Cell and Developmental Biology, 2021, 9: 749157.被引 5
  • Construction of an immunogenic cell death-based risk score prognosis model in breast cancer
    Li, Yanling; Feng, Jianyuan; Wang, Ting; Li, Mingcui; Zhang, Hanyu; Rong, Zhiyuan; Cheng, Weilun; Duan, Yunqiang; Chen, Ziang; Hu, Anbang; Yu, Tianshui; Zhang, Jiarui; Shang, Yuhang; Zou, Yiyun; Ma, Fei*; Guo, Baoliang*Frontiers in Genetics, 2022, 13: 1069921.被引 4
  • A Novel Platinum Resistance-Related Immune Gene Signature for Overall Survival Prediction in Patients with Ovarian Cancer
    Zhou, Chenfei; Ma, Junnan; Luo, Wanjun; Hu, Jiemei; Chen, Jing; Liang, Suiying; He, Shanyang*Biochemical Genetics, 2024, 62(1): 112-124.
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Genetics
发表日期
2022-11-08
卷期
第 13 卷
页码
1001239
DOI
10.3389/fgene.2022.1001239
期刊等级
3区
成果收录
SCIE
资助标注
Natural Science Foundation of Heilongjiang Province [YQ 2020H035]; National Cancer Center Climbing Fund [NCC201908B07]; Nn10 program of Harbin Medical University Cancer Hospital, China

作者

  • Z

    Zhang, Wenwen (第一作者)

    harbin med univ

  • L

    Liu, Tianbo

    harbin med univ

查看全部 6 位作者收起作者
  • J

    Jiang, Liangliang

    harbin med univ

  • C

    Chen, Jiarong

    harbin med univ

  • L

    Li, Qiuli

    harbin med univ

  • W

    Wang, Jing (通讯)

    harbin med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417